| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT02503462 Details | 2017-02-02 Interventional | 4 | 7 | Cobicistat Darunavir Ritonavir AIDS Dementia C… AIDS-related De… | No additional patients fulfilling the inclusion criteria - | |||
| NCT02050724 Details | 2017-02-02 Interventional | 2 | 11 | Technetium Tc 9… Bronchial Neopl… Multiple Pulmon… Solitary Pulmon… | Ende of part 1. Only few patients in part 2 enrolled - | |||
| NCT00301106 Details | 2017-02-02 Interventional | 1 | 2 | Interleukin-12 Breast Neoplasm… Breast Cancer Metastatic Canc… | protocol underwent significant revisions, decision made to terminate study and open as new
study listed NCT00849459 - | |||
| NCT02400385 Details | 2017-02-01 Interventional | 2 | 0 | Nivolumab Sunitinib Melanoma | With recent advances in immunotherapy scientific question not significant - | |||
| NCT02096315 Details | 2017-02-01 Interventional | 2 | - | Murepavadin Bronchiectasis Fibrosis Infections Respiratory Tra… Lower Respirato… | - - | |||
| NCT01703260 Details | 2017-02-01 Interventional | 2 | 20 | Pioglitazone Fatty Liver Non-alcoholic F… Nonalcoholic St… | Company decision; No safety or efficacy concerns (see detailed description) - | |||
| NCT00362700 Details | 2017-02-01 Interventional | 2 | - | Clevudine Hepatitis Hepatitis B | - - | |||
| NCT00362505 Details | 2017-02-01 Interventional | 3 | - | Clevudine Hepatitis Hepatitis B | - - | |||
| NCT00313287 Details | 2017-02-01 Interventional | 3 | - | Clevudine Hepatitis Hepatitis B | - - | |||
| NCT00313274 Details | 2017-02-01 Interventional | 3 | - | Clevudine Hepatitis Hepatitis B | - - | |||
| NCT00927147 Details | 2017-01-31 Interventional | 1/2 | 17 | Cetuximab Head and Neck N… Head and Neck C… | The neutron facility closed down for financial reasons. - | |||
| NCT02417129 2014-004544-36 Details | 2017-01-30 Interventional | 3 | 2 | Rituximab Lymphoma Lymphoma, Folli… Lymphoma, Non-H… | - As the program was prematurely discontinued and only two patients were randomized at the time of discontinuation, the planned statistical analysis was not performed and safety data are therefore presented in this abbreviated Clinical Trial Report. | |||
| NCT01389076 Details | 2017-01-30 Interventional | 2 | 22 | Methotrexate Tositumomab I-1… Lymphoma Lymphoma, Folli… Follicular Lymp… | Bexxar isn't being produced by the manufacturer as of Feb. 2014 This trial was abandoned prematurely due to the withdrawal of Bexxar by the manufacturer and failure to find another supplier. | |||
| NCT01957410 Details | 2017-01-27 Interventional | 2 | 13 | Ketamine Depression Depressive Diso… Depressive Diso… Major Depressiv… | Clinical Team decision to terminate the study after the results from Cohort 1 did not support
conducting Cohort 2. Study was planned as open label treatment phase (Cohort 1) and double blind treatment phase (Cohort 2). However, study was terminated after completion of Cohort 1. | |||
| NCT01717040 Details | 2017-01-27 Interventional | 4 | 37 | Pioglitazone Bipolar Disorde… Insulin Resista… | The study ended early due to budgetary issues - | |||
| NCT02179151 Details | 2017-01-26 Interventional | 3 | 108 | CKD732 Prader-Willi Sy… Syndrome Obesity | FDA Clinical Hold - | |||
| NCT01784900 2012-000475-17 Details | 2017-01-26 Interventional | 2 | 26 | Antibodies, Bis… Catumaxomab Carcinoma Peritoneal Neop… Patients With G… | - - | |||
| NCT00361114 Details | 2017-01-26 Interventional | 3 | 112 | Chlorproguanil Dapsone Fanasil, pyrime… Pyrimethamine Sulfadoxine Malaria | SP arms were stopped due to high levels of treatment failure.CD not available. - | |||
| NCT02204345 2014-001498-15 Details | 2017-01-25 Interventional | 1/2 | 12 | Carboplatin Paclitaxel Carcinoma, Non-… Lung Neoplasms Squamous Non-Sm… | - - | |||
| NCT02096133 2014-000728-97 Details | 2017-01-25 Interventional | 2 | 54 | Cholecalciferol Vitamin D Multiple Sclero… Sclerosis | difficulties with inclusion - |